Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
SYKStryker Corporation
FinDog View：Bullish
| Metric | ABT | SYK |
|---|
| Close | 102.36 | 284.76 |
| Market Cap | $177B | $109B |
| 1M | −7.26% | −14.15% |
| P/E (TTM) | 33.2 | 29.3 |
| Forward P/E | 18.1 | 21.8 |
| P/E 5-Yr Percentile | 66 | 1 |
| P/S | 3.9 | 4.2 |
| P/B | 3.5 | 4.6 |
| Dividend Yield | 1.98% | 1.02% |
| Latest Quarter Revenue | $11.2B | $6.6B |
| Revenue YoY | +7.8% | +9.4% |
| Gross Margin | 56.2% | 68.3% |
| Latest Quarter EPS | 0.61 | 3.30 |
| Avg Post-Earnings Move | ±1.6% | ±4.3% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.81% | 1.21% |
| 90-Day Net Insider Buying | −$46.7M | −$118M |
ABT · Revenue, Last 8 Quarters ($B)
SYK · Revenue, Last 8 Quarters ($B)
